| Dr Clarice Law Eyre, DMD, MS | |
|
100 Ucla Medical Plz Ste 350, Los Angeles, CA 90095-0001 | |
| (310) 794-5750 | |
| Not Available |
| Full Name | Dr Clarice Law Eyre |
|---|---|
| Gender | Female |
| Speciality | Dentist - Orthodontics And Dentofacial Orthopedics |
| Location | 100 Ucla Medical Plz Ste 350, Los Angeles, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003038142 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223P0221X | Dentist - Pediatric Dentistry | 43456 (California) | Primary |
| 1223X0400X | Dentist - Orthodontics And Dentofacial Orthopedics | 43456 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Clarice Law Eyre, DMD, MS 1248 S Sycamore Ave, Los Angeles, CA 90019-1533 Ph: (323) 931-7264 | Dr Clarice Law Eyre, DMD, MS 100 Ucla Medical Plz Ste 350, Los Angeles, CA 90095-0001 Ph: (310) 794-5750 |
News Archive
VaxOnco, a leading oncology biopharmaceutical company, today announced that following FDA IND approval, it will sponsor a Phase I folate receptor alpha-targeted therapeutic vaccine clinical trial in disease-free patients, previously diagnosed with either breast or ovarian cancer at Mayo Clinic.
In a new study of more than 125,000 pregnant women in Sweden, researchers at the Sahlgrenska Academy found that the risk of hepatobiliary cancer and immune-mediated and cardiovascular diseases later in life is higher in women with intrahepatic cholestasis of pregnancy (ICP) than in women without this condition.
A new study by researchers at Hospital for Special Surgery in New York City could help orthopedic surgeons better identify which patients will benefit most from surgery to correct debilitating age-related deterioration of their foot arches.
Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
› Verified 2 days ago
Dr. Kyung A Lim, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 827 S Berendo St Apt 202, Los Angeles, CA 90005 Phone: 213-219-2530 | |
Sonia Khullar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 132 S Vermont Avenue, Suite #210, Los Angeles, CA 90004 Phone: 213-389-2625 Fax: 213-389-4736 | |
Dr. William W Morgan, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 100 Ucla Medical Plz Ste 350, Los Angeles, CA 90095 Phone: 310-794-5750 | |
Dr. Arjang Vahidnia, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 7162 Beverly Blvd, #543, Los Angeles, CA 90036 Phone: 310-443-3030 | |
Dr. Adrian Sanchez, Dentist Medicare: Not Enrolled in Medicare Practice Location: 6114 York Blvd, Suite C, Los Angeles, CA 90042 Phone: 323-255-6698 | |
Dr. Bindu Vasudevan Pillai, DDS Dentist Medicare: Medicare Enrolled Practice Location: 5207 Whittier Blvd, Los Angeles, CA 90022 Phone: 323-269-0266 |